Origin of Neuromodulator in the Retina Pinpointed
Northwestern Medicine scientists have discovered that amacrine cells produce nitric oxide, a neuromodulator that regulates blood dilation, in a recently published study.
Browsing: "Research"
Critical Mass
Armed with a prestigious new grant, investigators prepare to rapidly translate scientific breakthroughs into better brain tumor therapies. Read the story in Northwestern Medicine magazine.
An Exceptional Cancer Center
The Lurie Cancer Center solidifies its place among the country’s elite after extraordinary growth and a top rating from the National Cancer Institute. Read the story in Northwestern Medicine magazine.
Les Turner ALS Symposium Celebrates Research and Patient Care
The 8th Annual Les Turner Symposium brought together investigators, clinicians, patients and families to share the latest discoveries in ALS research, promote scientific collaboration and provide patient education.
Genetic Variants in Caffeine Perception
The more sensitive a person is to the bitter taste of caffeine, the more coffee they tend to drink, according to a new study.
Krainc Honored at American Neurological Association Meeting
Dimitri Krainc, MD, received the Soriano Award at the American Neurological Association (ANA) 143rd Annual Meeting.
Epigenetics: Landscape of Disease
The Simpson Querrey Center for Epigenetics is connecting the Northwestern academic and medical community to integrate the study of epigenetics into science and clinical care.
New Inhibitor Improves Autism-Like Symptoms in Mice
A Northwestern University experimental therapeutic targeting a specific protein kinase reversed neurological symptoms in a mouse genetic model of autism, according to a recent Northwestern Medicine study.
New Therapeutic Target for Metabolic Disorders
Scientists have identified a novel regulator of liver metabolism, which could serve as a potential therapeutic target for obesity, type 2 diabetes and related conditions.
Mechanisms of Mitochondrial Dysfunction in ALS
Northwestern Medicine scientists have demonstrated that mitochondrial damage plays a critical early role in a group of diseases, including forms of ALS and dementia.